BioSpace News Archive

Bio NC

RedHill Biopharma Announces EU Orphan Drug Designation for RHB-204 for NTM Infections

RedHill Biopharma today announced that the European Commission has granted Orphan Drug Designation to RHB-2041 for the treatment of nontuberculous mycobacteria (NTM) disease.

August 17, 2022
·
10 min read
Nuvo Group and Sheba Medical Center’s “Sheba BEYOND” Complete First Phase of Collaboration to Create a Virtual Obstetric Solution

Nuvo Group announced today that it has completed the first phase of its collaboration agreement with Israel’s Sheba Medical Center’s “Sheba BEYOND”, one of the Top Ten medical centers in the world (NEWSWEEK) and a global leader in biotechnological innovation.

August 17, 2022
·
5 min read
Drug Development

PAN-TB Collaboration to Advance Investigational Tuberculosis Drug Regimens to Phase 2 Clinical Trials

The Project to Accelerate New Treatments for Tuberculosis (PAN-TB) collaboration announced today the execution of a joint development agreement (JDA) supporting the progression of two investigational tuberculosis (TB) combination treatment regimens into phase 2 clinical development.

August 17, 2022
·
14 min read
BioCapital

Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Provisional Approval in New Zealand as a First and Second Booster for Adults

Nuvaxovid™ is New Zealand’s first and only protein-based COVID-19 vaccine Nuvaxovid™ can now be used as a first or second booster dose for adults aged 18 and older vaccinated with any primary series vaccine.

August 17, 2022
·
12 min read
Pharm Country

HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

Harmony Biosciences Holdings, Inc. today announced that Harmony’s management will participate in the following upcoming investor conference.

August 17, 2022
·
1 min read
Biotech Bay

Atomwise Signs Strategic Multi-Target Research Collaboration with Sanofi for AI-Powered Drug Discovery

Atomwise, a leader in using artificial intelligence (AI) for small molecule drug discovery, today announced that it has established a strategic and exclusive research collaboration with Sanofi that will leverage its AtomNet® platform for computational discovery and research of up to five drug targets.

August 17, 2022
·
3 min read
Business

PerkinElmer Announces Finance Leadership Transition

PerkinElmer, Inc. today announced that Senior Vice President and Chief Financial Officer Jamey Mock will be transitioning from the Company to pursue an outside opportunity.

August 17, 2022
·
3 min read
Business

Mytide Therapeutics Partners with Agilent to Collaborate on Automation Solutions for Mytide’s Next-generation Manufacturing Platform

Mytide Therapeutics has partnered with Agilent, a global leader in life science, diagnostic and applied chemical markets.

August 17, 2022
·
4 min read
Business

Cybin and Clinilabs Granted Schedule I DEA License for CYB003 Phase 1/2a First-In-Human Clinical Trial

Cybin Inc. and Clinilabs Drug Development Corporation today announced that the U.S. Drug Enforcement Agency (“DEA”) has granted a Schedule I license to support the first-in-human Phase 1/2a clinical trial of CYB003, a proprietary deuterated psilocybin analog that is being developed for the treatment of major depressive disorder (“MDD”).

August 17, 2022
·
8 min read
Genetown

Gelesis to Participate in Fireside Chat with IPO Edge Today at 2:00 PM ET

Gelesis Holdings Inc. today announced that the Company is participating in a fireside chat with IPO Edge today at 2:00 PM ET.

August 17, 2022
·
7 min read